Decision Resources acquires Manhattan Research

Share this article:

Decision Resources announced the acquisition of Manhattan Research on June 17.  The move will expand Decision Resources' global physician and consumer digital market research portfolio, according to a statement.  Terms of the deal were not disclosed to the public.

“Part of Decision Resources' big goal is to grow our business both organically, and to build a stable of premier market research firms that focus on specific areas of the healthcare industry,” said Elizabeth Marshall, director of marketing at Decision Resources.  Marshall cites Millennium Research Group and HealthLeaders as two examples of other research firms providing Decision Resources with a specialized focus: Millennium for medical devices and technology, and HealthLeaders for managed care.  “We're looking at the bigger picture and the healthcare industry as a whole – we're offering clients an integrated model,” says Marshall.  

Manhattan Research will remain headquartered in New York, NY.  Decision Resources is located in Waltham, MA.  Other companies owned by Decision Resources include Arlington Medical Resources, which was acquired last December, and Fingertip Formulary, acquired in March. 

Share this article:

Email Newsletters

More in News

Lack of marketing partner delays Afrezza launch

Lack of marketing partner delays Afrezza launch

Afrezza was heralded as one of the most innovative diabetes products of the last decade. So, why hasn't MannKind set a firm launch date for the product?

In sunny world of LASIK marketers, a dark underbelly

In sunny world of LASIK marketers, a dark ...

Last week, the former FDA branch chief who originally approved LASIK machines asked FDA to reconsider its denial last month of his petition to ban these devices.

BMS Q2 sales slip, Eliquis, Yervoy soar

BMS Q2 sales slip, Eliquis, Yervoy soar

The company attributed part of the Eliquis boost to the BMS-Pfizer DTC and education efforts.